Lander Energy Corporation

August 17, 2011 14:31 ET

Lander Energy Corporation Announces Conditional Approval of Qualifying Transaction with Valentus Medical Technologies Inc.

TORONTO, ONTARIO--(Marketwire - Aug. 17, 2011) - LANDER ENERGY CORPORATION ("Lander", or the "Company") (TSX VENTURE:LAE.H) is pleased to announce that the TSX Venture Exchange (the "TSXV") has conditionally accepted the Company's previously announced proposed qualifying transaction (the "Qualifying Transaction") with Valentus Medical Technologies Inc. ("Valentus") located in Victoria, British Columbia.

Final approval of the Qualifying Transaction is subject to the completion of the Company's previously announced private placement financing (the "Offering") by the Company for aggregate gross proceeds of at least $3,500,000, and the completion of satisfactory background searches and receipt of final materials by the TSXV. The Company will pay finder's fees to certain arm's length finders of up to 10% of the proceeds raised pursuant to the Offering by such finders in accordance with TSXV policies. Proceeds of the Offering will be used to accelerate sales and marketing efforts of its medical technologies and to expedite the opening of pain relief clinics in Canada.

The Company also announces that it has filed a filing statement (the "Filing Statement") dated August 11, 2011, in connection with the Qualifying Transaction. A copy of the Filing Statement is available on SEDAR at

"We are confident of the market acceptance of our technologies as demonstrated with product sales to Naturopaths, Chiropractors, Acupuncturists, Registered Massage Therapists, the Saskatchewan Rough Riders, and Finlandia Pharmacy to date in 2011. Signed agreements have also been put in place in Turkey and Dubai as part of our International Distribution network", says Stephen Davis, CEO of Valentus.

Valentus is a privately owned company incorporated under the Business Corporations Act (British Columbia), with its head office in Victoria, British Columbia. Valentus works closely with carefully selected manufacturers and inventors to bring their non-invasive, proven products to forward-thinking, innovative practitioners and into use in its wholly owned clinics.

The securities described herein have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States unless registered under the Act or unless an exemption from registration is available.

Forward-looking Statements

This release includes certain statements that may be deemed to be "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that management of the Company expect, are forward-looking statements. Actual results or developments may differ materially from those in forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, save and except as may be required by applicable securities laws.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Contact Information